Latest filing published 14 Feb 2014 for CANNABIS SCIENCE, INC., €35k.
Insider track record
No signal scores available.
Robert Melamede: trading record in brief
Robert Melamede appears in our data through filings on Cannabis Science, Inc. shares, published by SEC (Form 4). We count 30 filings; the first trade dates from 2 January 2014 and the latest from 13 February 2014.
On the market, this insider has only sold: 30 sales, €599k in total.
Most recently, on 14 February 2014, the filings show an open-market sale worth €35k in Cannabis Science, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert Melamede
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 275,700 shares@ US$0.1709Common stock, $.001 par valueSEC:0001517126-14-000055:0
- 150,100 shares@ US$0.1753Common stock, $.001 par valueSEC:0001517126-14-000055:1
- 253,400 shares@ US$0.2211Common stock, $.001 par valueSEC:0001517126-14-000048:0
- 304,500 shares@ US$0.1814Common stock, $.001 par valueSEC:0001517126-14-000048:1
- 221,300 shares@ US$0.1617Common stock, $.001 par valueSEC:0001517126-14-000048:2
- 230,100 shares@ US$0.2521Common stock, $.001 par valueSEC:0001517126-14-000046:0
- 243,200 shares@ US$0.2497Common stock, $.001 par valueSEC:0001517126-14-000046:1
- 215,300 shares@ US$0.1802Common stock, $.001 par valueSEC:0001517126-14-000039:0
- 221,400 shares@ US$0.1883Common stock, $.001 par valueSEC:0001517126-14-000039:1
- 223,000 shares@ US$0.2057Common stock, $.001 par valueSEC:0001517126-14-000039:2
- 188,300 shares@ US$0.2047Common stock, $.001 par valueSEC:0001517126-14-000038:0
- 200,000 shares@ US$0.1771Common stock, $.001 par valueSEC:0001517126-14-000038:1
- 211,900 shares@ US$0.1833Common stock, $.001 par valueSEC:0001517126-14-000038:2
- 168,800 shares@ US$0.1306Common stock, $.001 par valueSEC:0001517126-14-000035:0
- 174,200 shares@ US$0.1422Common stock, $.001 par valueSEC:0001517126-14-000035:1
- 182,000 shares@ US$0.1597Common stock, $.001 par valueSEC:0001517126-14-000035:2
- 152,600 shares@ US$0.0832Common stock, $.001 par valueSEC:0001517126-14-000032:0
- 159,200 shares@ US$0.1116Common stock, $.001 par valueSEC:0001517126-14-000032:1
- 164,700 shares@ US$0.1213Common stock, $.001 par valueSEC:0001517126-14-000032:2
- 136,400 shares@ US$0.1105Common stock, $.001 par valueSEC:0001517126-14-000025:0
- 141,100 shares@ US$0.0942Common stock, $.001 par valueSEC:0001517126-14-000025:1
- 148,300 shares@ US$0.0832Common stock, $.001 par valueSEC:0001517126-14-000025:2
- 116,900 shares@ US$0.1307Common stock, $.001 par valueSEC:0001517126-14-000010:0
- 131,900 shares@ US$0.1168Common stock, $.001 par valueSEC:0001517126-14-000010:1
- 77,300 shares@ US$0.1031Common stock, $.001 par valueSEC:0001517126-14-000005:0
25 of 30 declarations